Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
about
Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patientLipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.Novel approaches to drug discovery for the treatment of type 2 diabetes.Commensal bacteria make GPCR ligands that mimic human signalling molecules.Therapeutic application of GPR119 ligands in metabolic disorders.Investigational insulin secretagogues for type 2 diabetes.YH18421, a novel GPR119 agonist exerts sustained glucose lowering and weight loss in diabetic mouse model.
P2860
Q33759570-B03D84BC-54EC-42EC-B150-84CEFD94F937Q36677839-F7BDB36B-C89E-4F0C-A42E-CC73916C71BEQ38233063-08FA4967-B609-425B-B306-53E393B69102Q38635610-B21F8118-C772-4114-872A-E7047C8E78AEQ38655382-E4ECA811-66C4-4709-94CB-17741C6D2D02Q38735419-F22125C0-0A50-4FCD-9707-CAE073E93017Q38737053-7350F853-D9DF-4A88-81C3-60DC3F9C0158
P2860
Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
@en
type
label
Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
@en
prefLabel
Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
@en
P2093
P2860
P1476
Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
@en
P2093
Chun Hwa Kim
Dae Hoon Kim
Hyo-Sun Choi
Jae-Keol Rhee
Soo Hyun Park
Tae-Young Ha
Young-Seok Kim
P2860
P2888
P304
P356
10.1007/S12272-013-0209-0
P577
2013-07-30T00:00:00Z
P6179
1028661910